NMG
AMED

New Millennium Group’s Amedisys AMED Stock Holding History

New Millennium Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7
Closed -$636 – 471
2024
Q4 		$636 Buy
+7
New +$643 ﹤0.01% 511

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

New Millennium Group's AMED Position: Q1 2025 in Review

New Millennium Group sold out of Amedisys (AMED) in Q1 2025, closing a stake of 7 shares — an estimated $636 sold.

New Millennium Group first reported a position in AMED in Q4 2024 and held it in 1 quarter. The position peaked at $636 in Q4 2024. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • New Millennium Group reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • New Millennium Group sold 7 Amedisys shares in Q1 2025, an estimated $636.
  • New Millennium Group first reported a position in Amedisys in Q4 2024 and held it in 1 quarter.
  • New Millennium Group's Amedisys position peaked at $636 in Q4 2024.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on New Millennium Group's 13F filing for Q1 2025, filed 25 Apr 2025.